The Galectin-3 protein is a family of animal lectins that has affinity for β-galactosides through a conserved carbohydrate-recognition domain (CRD). Galectin-3 not only exists in old species but also in mammals, implying that Glaectin-3 plays an important and essential role in cell biology. Galectin-3 has been considered related to cell growth and differentiation, apoptosis and immune response. Most important of all, the expression of Galectin-3 increases in many types of cancer such as thyroid and pancreas cancer. Galectin-3 can facilitate metastasis by promoting cancer cell adhesion and invasiveness. In this research, CRD domain and full length Galectin-3 were used to study their affinity to lactose and a small synthetic peptide. From the NMR HSQC mapping of CRD, twenty-three residues were found to be affected upon binding where residues Arg144, Asn160, Asn174, Trp181, Glu184 and Arg186 were consistent with the previous X-ray results by Collins, et al. showing that they are in the vicinity of the lactose binding site. For the full-length Galectin-3, similar results were obtained. In the peptide-galectin binding experiments, no significant differences were found between free and peptide-titrated samples in the HSQC spectra. The synthetic peptide might bind to the protein in a non-specific way at high concentration which reduces the solubility of Galectin-3 and induces the formation of precipitations. This research work is served as a pilot study for our future work on the protein binding affinity and specificity using Galectin-3 as a model system.